Diabetes mellitus (DM): Nursing process (ADPIE)

3,829views

Diabetes mellitus (DM): Nursing process (ADPIE)

SHRAVAM

SHRAVAM

Gastrointestinal system anatomy and physiology
Fractures: Nursing process (ADPIE)
Anaphylaxis: Nursing process (ADPIE)
Lyme disease: Nursing process (ADPIE)
Vaccines: Nursing pharmacology
Immunoglobulins: Nursing pharmacology
Immunosuppressants for autoimmune diseases: Nursing pharmacology
Appendicitis: Nursing process (ADPIE)
Celiac disease: Nursing process (ADPIE)
Cirrhosis: Nursing process (ADPIE)
Gastroesophageal reflux disease (GERD): Nursing process (ADPIE)
Hiatal hernia: Nursing process (ADPIE)
Pancreatitis: Nursing process (ADPIE)
Peptic ulcer disease (PUD): Nursing process (ADPIE)
Antacids: Nursing pharmacology
Antidiarrheals: Nursing pharmacology
Laxatives: Nursing pharmacology
Weight loss medications: Nursing pharmacology
Antiemetics: Nursing pharmacology
Gallstone-dissolving agents: Nursing pharmacology
Gastric mucosal protective agents: Nursing pharmacology
Antispasmodics (GI): Nursing pharmacology
Histamine H2 antagonists: Nursing pharmacology
Proton pump inhibitors (PPIs): Nursing pharmacology
Treatment for Helicobacter pylori: Nursing pharmacology
Diuretics - Osmotic and carbonic anhydrase inhibitors: Nursing pharmacology
Cholinergic therapy (GU): Nursing pharmacology
Diabetes insipidus: Nursing process (ADPIE)
Diabetes mellitus (DM): Nursing process (ADPIE)
Diabetic ketoacidosis (DKA): Nursing process (ADPIE)
Hyperosmolar hyperglycemic state (HHS): Nursing process (ADPIE)
Hyperthyroidism: Nursing process (ADPIE)
Hypothyroidism: Nursing process (ADPIE)
Syndrome of inappropriate antidiuretic hormone (SIADH): Nursing process (ADPIE)
Medications for antidiuretic hormone (ADH) disorders: Nursing pharmacology
Medications for thyroid disorders: Nursing pharmacology
Non-insulin injectable antidiabetic drugs - GLP-1 agonists and amylinomimetics: Nursing pharmacology
Oral antidiabetic medications - Alpha-glucosidase inhibitors: Nursing pharmacology
Oral antidiabetic medications - Biguanides and thiazolidinediones: Nursing pharmacology
Oral antidiabetic medications - DPP-4 inhibitors: Nursing pharmacology
Oral antidiabetic medications - Sulfonylureas and meglitinides: Nursing pharmacology
Oral antidiabetic medications - Sodium-glucose co-transporter-2 (SGLT-2) inhibitors: Nursing pharmacology
Insulin: Nursing pharmacology
Epistaxis: Nursing process (ADPIE)
Eye injury: Nursing process (ADPIE)
Glaucoma: Nursing process (ADPIE)
Tonsillitis: Nursing process (ADPIE)
Antiglaucoma medications: Nursing pharmacology
Eye anesthetics: Nursing pharmacology
Mydriatics and cycloplegics: Nursing pharmacology
Ophthalmic anti-inflammatories and anti-infectives: Nursing pharmacology
Acute compartment syndrome: Nursing process (ADPIE)
Gout: Nursing process (ADPIE)
Musculoskeletal injuries: Nursing process (ADPIE)
Rheumatoid arthritis (RA): Nursing process (ADPIE)
Acetylcholinesterase inhibitors for myasthenia gravis: Nursing pharmacology
Analgesics: Nursing pharmacology
Antiepileptics: Nursing pharmacology
Medications for Alzheimer disease: Nursing pharmacology
Skeletal muscle relaxants: Nursing pharmacology
Meningitis: Nursing process (ADPIE)
Parkinson disease: Nursing process (ADPIE)
Seizure disorder: Nursing process (ADPIE)
Stroke: Nursing process (ADPIE)
Trigeminal neuralgia: Nursing process (ADPIE)
Breast cancer: Nursing process (ADPIE)
Tumor lysis syndrome (TLS): Nursing Process (ADPIE)
Plant extracts for chemotherapy: Nursing pharmacology
Peripheral arterial disease (PAD): Nursing process (ADPIE)
Peripheral venous disease (PVD): Nursing process (ADPIE)
Chickenpox (Varicella): Nursing process (ADPIE)
Conjunctivitis: Nursing process (ADPIE)
Hydrocephalus: Nursing process (ADPIE)
Poisoning: Nursing process (ADPIE)
Pyloric stenosis: Nursing process (ADPIE)
Reye syndrome: Nursing process (ADPIE)
Bronchiolitis and respiratory syncytial virus (RSV): Nursing process (ADPIE)
Pharmacokinetics - Elimination: Nursing pharmacology
Anthelmintics: Nursing pharmacology
Antibiotics - Aminoglycosides: Nursing pharmacology
Antibiotics - Cephalosporins: Nursing pharmacology
Antibiotics - Fluoroquinolones: Nursing pharmacology
Antibiotics - Macrolides: Nursing pharmacology
Antibiotics - Metronidazole: Nursing pharmacology
Antibiotics - Oxazolidinones: Nursing pharmacology
Antibiotics - Tetracyclines and glycylcyclines: Nursing pharmacology
Antibiotics - Trimethoprim and sulfonamides: Nursing pharmacology
Antibiotics - Polymyxins: Nursing pharmacology
Antibiotics - Cyclic lipopeptides: Nursing pharmacology
Antiprotozoals: Nursing pharmacology
Antivirals for herpesviruses: Nursing pharmacology
Antibiotics - Glycopeptides: Nursing pharmacology
Antimalarials: Nursing pharmacology
Antivirals for hepatitis B and C: Nursing pharmacology
Antibiotics - Lincosamides: Nursing pharmacology
Antibiotics - Antimycobacterials: Nursing pharmacology
Angiotensin II receptor blockers (ARBs): Nursing pharmacology
Angiotensin-converting enzyme (ACE) inhibitors: Nursing pharmacology
Beta-adrenergic blockers: Nursing pharmacology
Calcium-channel blockers: Nursing pharmacology
Cardiac glycosides: Nursing pharmacology
Direct-acting vasodilators: Nursing pharmacology

Notes

DIABETES MELLITUS

KEY POINTS
NOTES
PATIENT REPORT
  • 63-year-old man
  • History type 2 diabetes
  • Metformin, glyburide
  • Hemoglobin A1C 8.9%
  • Numbness in feet

PATHOPHYSIOLOGY
  • Diabetes
    • Glucose unable to move from blood into cells
    • Cells starve for energy despite high glucose levels
    • Insulin's function impaired
    • Type 1
      • Autoimmune destruction of pancreatic beta cells
    • Type 2
      • Cells resistant to insulin
  • Insulin
    • Produced by pancreatic beta cells
    • Stimulates uptake of glucose into cells
  • Signs and symptoms
    • Polyuria
    • Polydipsia
    • Polyphagia
    • Diabetic ketoacidosis
    • Hyperosmolar hyperglycemic state
  • Complications
    • Peripheral vascular disease
    • Myocardial infarction
    • Stroke
    • Nephropathy
    • Retinopathy
    • Neuropathy
    • Ulcers

DIAGNOSIS AND TREATMENT
  • Diagnosis
    • Measuring blood glucose levels
    • Hemoglobin A1C
  • Treatment
    • Insulin
    • Lifestyle changes
    • Oral or injectable antidiabetic medications

ASSESSMENT
  • Glucose running high last few months
    • > 200 mg/dL (11.1 mmol/L) most of the time
  • Takes medications as prescribes
  • Avoids sweets 
  • Does not follow particular diet
  • Occasional yard work and gardening
  • Recent numbness in feet
  • Cool and dry feet
  • 2+ pedal pulses
  • Temperature: 97.9 F (36.6 C)
  • Heart rate: 68
  • Respiratory rate: 18
  • Lungs clear
  • Blood pressure: 142/80 mmHg
  • Pain: 0/10
  • Oxygen saturation: 96% room air
  • 5'11''
  • 192 lbs (87 kg)
  • Hemoglobin A1C: 8.9%
  • Fasting glucose: 117 mg/dL (6.5 mmol/L)
  • Monofilament test: moderate loss of sensation in feet bilaterally

NURSING DIAGNOSES
  • Unstable blood glucose related to insufficient diabetes management
  • Risk for injury related to impaired peripheral arterial circulation and decreased neurosensory function
  • Readiness for enhanced health management related to desire to prevent complications

PLANNING
  • Maintain glucose in normal range
  • Reduce A1C
  • Keep feet free from injury and sores
  • Incorporate treatments into lifestyle 

IMPLEMENTATION
  • Teach about long-acting insulin
  • Regular glucose monitoring
  • Keep regular appointments
  • How to recognize hypoglycemia
  • Adverse effects to report
  • Lifestyle changes
  • Foot care
  • Develop personalized meal plan

EVALUATION
  • Hemoglobin A1C: 7.9%
  • Glucose log averages 170-190 mg/dL (9.4-10.6 mmol/L)
  • Increased physical activity
  • Making healthier food choices
  • Weight loss of 8 lbs
  • No sores or cracking on feet

Transcript

Watch video only

Harold Owl is a 63-year-old male client with a history of type 2 diabetes who is referred to the endocrinology clinic by his primary care provider for evaluation.

Mr. Owl takes the biguanide metformin and sulfonylurea glyburide to manage his diabetes, but his latest hemoglobin A1c, or HbA1c test, was 8.9% and he has recently developed numbness in his feet.

In diabetes mellitus, commonly just called diabetes, the body has trouble moving glucose from the blood into the tissue cells.

As a result, cells starve for energy despite having high blood glucose levels, which is called hyperglycemia.

Normally, high blood glucose stimulates the pancreatic beta cells to produce and secrete the hormone insulin, which in turn reduces blood glucose by stimulating the uptake of glucose into the cells. In diabetes, the blood glucose stays high because insulin’s function is impaired.

There are two main types of diabetes. In type 1 diabetes, there’s autoimmune destruction of the pancreatic beta cells, so they can’t produce and secrete insulin.

The exact cause of type 1 diabetes is unknown, but it’s thought to have a genetic and environmental component, and risk factors include personal or family history of type 1 diabetes, as well as celiac disease, and thyroid disease.

The onset is usually abrupt, generally appears before the age of 30, and is most often diagnosed during childhood or puberty.

On the other hand, in type 2 diabetes, the pancreas is able to produce and secrete insulin, but the tissue cells tend to be insulin resistant, meaning they are unable to respond well to insulin stimulation.

Type 2 diabetes is associated with risk factors, like male sex, increasing age, or having a first degree relative with type 2 diabetes, a body mass index or BMI over 25, a sedentary lifestyle, or a cardiovascular disease like hypertension.

With type 2 diabetes, the symptoms usually begin after the age of 45, and gradually worsen over a few months.

Classic symptoms of both type 1 and type 2 diabetes include polyuria, which means that individuals urinate frequently, which is associated with polydipsia, which means they are constantly thirsty and drink a lot of water.

Many clients also present with polyphagia, which is a fancy way to say they have a large appetite, and is associated with unexplained weight loss because tissue cells can’t uptake the glucose from food, so they instead use fatty acids from adipose tissue, called lipolysis.

Now, clients with type 1 diabetes are at risk for a serious acute complication called diabetic ketoacidosis, or DKA for short.

This occurs because, after lipolysis, the liver turns the fatty acids into ketone bodies, which increase the acidity of the blood.

As a result, clients can develop nausea, vomiting, dehydration, and a characteristic fruity smelling breath, as well as a deep and labored breathing called Kussmaul respirations.

Severe cases of DKA can also cause mental status changes and acute cerebral edema.

An acute complication that is much more common in type 2 diabetes is called hyperosmolar hyperglycemic state, or HHS, which is characterized by extreme hyperglycemia, along with increased urination.

This can cause severe dehydration, as well as nausea, vomiting, and mental status changes.

Alright, now over time, the hyperglycemia that occurs with uncontrolled diabetes can cause damage to the blood vessels, leading to long-term or chronic complications.

These include macrovascular complications due to damage to the larger blood vessels, resulting in peripheral vascular disease, myocardial infarction, and stroke.

Diabetes can also cause microvascular complications due to damage to the tiny blood vessels throughout the body.

In the kidneys, microvascular damage ultimately leads to diabetic nephropathy, which causes renal insufficiency and failure. In the eyes, microvascular damage can lead to diabetic retinopathy and can eventually cause blindness.

Diabetes can also affect the peripheral nerves, causing diabetic neuropathy, which is characterized by decreased sensation in the toes and fingers, sometimes called a stocking-glove distribution, as well as autonomic neuropathy, resulting in problems like delayed gastric emptying, called gastroparesis, as well as urinary retention, or neurogenic bladder, and erectile dysfunction in males.

Finally, a combination of microvascular damage and neuropathy can lead to the formation of diabetic foot ulcers, which can become infected easily, are slow to heal, and increase the risk of lower extremity amputation.

Diagnosing type 1 or type 2 diabetes is typically done by measuring blood glucose levels.

A random blood sample can be taken anytime, or very commonly, a fasting glucose sample where the person doesn’t eat or drink anything except water for 8 hours.

A fasting blood glucose level of 100-125 mg/dL is considered prediabetes, and if it's 126 mg/dL or higher on two separate occasions, the client has diabetes.

A non-fasting or random glucose test can be done at any time, with 200 mg/dL or higher being a red flag for diabetes.

Another test is called an oral glucose tolerance test, where a person is given glucose, and then blood samples are taken at time intervals to figure out how well it’s being cleared from the blood.

At the time interval of 2 hours later, a glucose level of 200 or above indicates diabetes.

Another type of test that can be done is the HbA1c test, which tests for the proportion of hemoglobin in red blood cells that has glucose stuck to it, called glycosylated hemoglobin.

Sources

  1. "Ackley and Ladwig’s Nursing Diagnosis Handbook: An Evidence-Based Guide to Planning Care, 13th edition" Mosby (2022)
  2. "Genetics of diabetes mellitus and diabetes complications" Nat Rev Nephrol (2020)
  3. "Harrison’s Principles of Internal Medicine, 21st edition" McGraw Hill / Medical (2022)
  4. "Definition, Classification and Diagnosis of Diabetes Mellitus" Exp Clin Endocrinol Diabetes (2019)
  5. "Diabetes, cardiovascular disease and the microcirculation" Cardiovasc Diabetol (2021)
  6. "Critical Care Nursing: Diagnosis and Management, 9th edition" Elsevier (2021)